Top 5 dermatology reads in February include light therapy for wrinkles

Study results finding that low-level light therapy significantly and safely improved facial skin wrinkles was among the most-read articles of February on Healio.com/Dermatology.

Other widely read articles in the month included the FDA approval of Siliq for treating plaque psoriasis and the Vitiligo Working Group’s recommendations for phototherapy treatment of vitiligo:

Low-level light therapy improved periocular wrinkles

Low-level light therapy significantly and safely improved facial skin wrinkles, according to study results published in Dermatologic Surgery.

Researchers in Korea conducted a prospective double-blind study of 52 women aged between 30 and 65 years with more than grade 3 lateral periocular wrinkles. Read more

FDA approves Siliq for treating psoriasis

The FDA announced today that it has approved Siliq as treatment for moderate-to-severe plaque psoriasis.

Siliq (brodalumab, Valeant Pharmaceuticals) is administered by injection and is intended for patients who are candidates for systemic therapy or phototherapy and have failed to respond or have stopped responding to other systemic therapies, according to a press release. Read more

Group makes recommendations for phototherapy treatment of vitiligo

The Vitiligo Working Group has made a set of recommendations regarding the use of narrowband ultraviolet B light for the treatment of vitiligo.

“Treatment of vitiligo with narrowband ultraviolet B light is an important component of the current standard of care,” the authors wrote. “However, there are no consistent guidelines regarding the dosing and administration of [narrow band ultraviolet B light] in vitiligo, reflected by varied treatment practices around the world.” Read more

Biologics for psoriasis may increase risk of squamous cell carcinoma

Patients with psoriasis who were treated with biologics had an increased incidence of cutaneous squamous cell carcinoma, according to study results recently published in the Journal of the American Academy of Dermatology.

Researchers used the Kaiser Permanent Northern California health plan to identify 5,889 adult members with psoriasis diagnosed between 1998 and 2011 who were treated with at least one systemic antipsoriatic agent. Read more

Survey shows dermatologists agree on sunscreen recommendations, safety

A majority of dermatologists agree that FDA-approved sunscreens protect against skin cancer and photoaging, recommend the use of sunscreen with an SPF of at least 30, and often use sunscreens with an SPF of at least 50, according to survey results published in JAMA Dermatology.

A survey was provided to U.S. dermatologists attending a national educational conference on April 9, 2016. Read more